People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

People with diabetes may also develop high blood pressure, which can lead to kidney damage. “Hypertension by itself is one of the main causes of kidney disease,” Shafipour said. “There’s a ...

With the FDA's approval, the medicine, chemically known as semaglutide, will become the first GLP-1 treatment option for persons with type 2 diabetes and chronic kidney disease. “Such an ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

About 40% of people with type 2 diabetes have chronic kidney disease, according to Novo Nordisk. Type 2 diabetes impacts approximately 37 million adults in the US, the company noted in a press ...

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and ... to manage blood pressure, including ACE inhibitors ...